These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3450870)

  • 1. Separation of muscarinic acetylcholine receptor entities from rat cerebral cortex by ion exchange chromatography.
    Pelzer H; Raible A
    J Recept Res; 1987; 7(6):845-57. PubMed ID: 3450870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
    Wang JX; Mei L; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex.
    Berrie CP; Birdsall NJ; Hulme EC; Keen M; Stockton JM
    Br J Pharmacol; 1985 Jul; 85(3):697-703. PubMed ID: 4027484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
    Evans RA; Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of solubilized muscarinic cholinergic receptors: binding and hydrodynamic properties.
    Baron B; Gavish M; Sokolovsky M
    Arch Biochem Biophys; 1985 Jul; 240(1):281-96. PubMed ID: 4015105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermodynamic analyses of pirenzepine binding to membrane-bound and solubilized muscarinic receptors from rat forebrain and heart.
    Mei L; Wang JX; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1987 Sep; 242(3):991-1000. PubMed ID: 3656121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
    Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB
    Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization and characterization of muscarinic receptors from bovine brain.
    Baron B; Abood LG
    Life Sci; 1984 Dec; 35(24):2407-14. PubMed ID: 6513721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of muscarinic receptor subtypes in bovine cerebral cortex by radiation inactivation and molecular exclusion h.p.l.c.
    Shirakawa O; Tanaka C
    Br J Pharmacol; 1985 Oct; 86(2):375-83. PubMed ID: 4052735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric distribution and down-regulation of the muscarinic acetylcholine receptor in rat cerebral cortex.
    Pediconi MF; Roccamo de Fernández AM; Barrantes FJ
    Neurochem Res; 1993 May; 18(5):565-72. PubMed ID: 8474575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glycoprotein nature of solubilized muscarinic acetylcholine receptors from bovine cerebral cortex.
    Shirakawa O; Kuno T; Tanaka C
    Biochem Biophys Res Commun; 1983 Sep; 115(3):814-9. PubMed ID: 6626225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
    Gao ZG; Liu CG
    Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific [3H]quinuclidinyl benzilate binding activity in digitonin-solubilized preparations from bovine brain.
    Hurko O
    Arch Biochem Biophys; 1978 Oct; 190(2):434-45. PubMed ID: 718161
    [No Abstract]   [Full Text] [Related]  

  • 19. Solubilization and sedimentation analysis of muscarinic acetylcholine receptors.
    Traish A; Moran E
    J Recept Res; 1991; 11(6):965-83. PubMed ID: 1753382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.